BEC hydrochloride salt form · hydrochloride · Parent BEC hydrochloride
BEC hydrochloride is a slow-binding and competitive Arginase II inhibitor.
For research use only. Not for human or veterinary use.
BEC hydrochloride structure
CAS No.: 222638-67-7
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 1 g | USD 400.00 | BP-01989A-1g | In stock | Get quote |
| 5 g | USD 1,450.00 | BP-01989A-5g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
BEC hydrochloride is a slow-binding and competitive Arginase II inhibitor with Ki of 0.31 μM and 30 nM at pH 7.5 and pH 9.5, respectively.
Biological activity
In Vitro The X-ray crystal structure of the arginase-BEC complex has been determined at 2.3 resolution from crystals perfectly twinned by hemihedry. The structure of the complex reveals that the boronic acid moiety undergoes nucleophilic attack by metal-bridging hydroxide ion to yield a tetrahedral boronate anion that bridges the binuclear manganese cluster, thereby mimicking the tetrahedral intermediate (and its flanking transition states) in the arginine hydrolysis reaction. In Vivo Administration of the arginase inhibitor BEC decreases arginase activity and causes alterations in NO homeostasis, which are reflected by increases in S-nitrosylated and nitrated proteins in the lungs from inflamed mice. BEC enhances perivascular and peribronchiolar lung inflammation, mucus metaplasia, NF-κB DNA binding, and mRNA expression of the NF-κB-driven chemokine genes CCL20 and KC, and leads to further increases in airways hyperresponsiveness.
Identifiers
- SMILES
-
Cl.N[C@@H](CSCCB(O)O)C(O)=O - InChIKey
-
GHPYJLCQYMAXGG-WCCKRBBISA-N
Specifications
- MW (average)
- 229.4900
- Formula
- C5H13BClNO4S
- CAS No.
- 222638-67-7
- Physical state
- Solid
- Color
- white to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO/water
Documents
References
Same research area
Search Metabolic Disease- BP-00002A Petrelintide acetate salt · >98%
- BP-00002 Petrelintide free base · >98%
- BP-00756 PF-07853578 free base · >98%
- BP-01824 TAK875 free base · >98%
- BP-01828 3-Deazaneplanocin A free base · >98%
- BP-01829 SYR-472 succinate free base · >98%
- BP-01830 LDK378 free base · >98%
- BP-01851A Icotinib hydrochloride salt · >98%